{"abnormal faeces": 2.45, "acute macular neuroretinopathy": 2.06, "administration site erythema": 3.35, "administration site oedema": 3.7, "administration site pain": 4.11, "antibody test": 12.28, "antibody test abnormal": 2.59, "antibody test negative": 3.5, "aortic thrombosis": 2.0, "application site induration": 2.36, "application site oedema": 3.29, "blood fibrinogen increased": 2.97, "body temperature": 2.04, "body temperature abnormal": 2.06, "body temperature increased": 3.69, "body temperature normal": 6.43, "capillary fragility": 2.1, "carotid artery thrombosis": 2.12, "cerebral thrombosis": 2.3, "cerebral venous sinus thrombosis": 5.22, "cerebral venous thrombosis": 3.23, "chills": 3.25, "covid-19": 3.11, "eye haematoma": 2.69, "eyelid bleeding": 2.0, "feeling cold": 2.47, "fibrin d dimer increased": 2.59, "guillain-barre syndrome": 2.82, "haemorrhoids thrombosed": 3.65, "headache": 2.36, "heparin-induced thrombocytopenia test positive": 14.23, "hepatic vein thrombosis": 4.56, "hyperaesthesia": 2.06, "hypotonia": 2.54, "incomplete course of vaccination": 2.88, "influenza": 3.92, "influenza like illness": 3.06, "injection site joint movement impairment": 2.0, "injection site joint pain": 2.03, "injection site movement impairment": 2.42, "injection site reaction": 3.09, "jugular vein thrombosis": 2.09, "limb discomfort": 4.21, "local reaction": 3.34, "locomotive syndrome": 7.94, "myalgia": 2.14, "myelin oligodendrocyte glycoprotein antibody-associated disease": 2.51, "ophthalmic vein thrombosis": 3.24, "oxygen saturation": 5.64, "periorbital haemorrhage": 2.02, "peripheral artery thrombosis": 2.51, "peripheral circulatory failure": 2.45, "peripheral vascular disorder": 3.24, "petechiae": 2.68, "phlebitis superficial": 3.03, "portal vein thrombosis": 2.13, "portosplenomesenteric venous thrombosis": 3.96, "pyrexia": 2.85, "respiratory depth decreased": 2.97, "rest regimen": 2.49, "retinal vascular thrombosis": 2.22, "reversed hot-cold sensation": 2.52, "sars-cov-2 antibody test": 4.48, "sars-cov-2 antibody test negative": 4.28, "sars-cov-2 test negative": 3.66, "sars-cov-2 test positive": 2.63, "severe acute respiratory syndrome": 25.33, "sigmoid sinus thrombosis": 11.78, "sudden cardiac death": 2.79, "superficial vein prominence": 3.66, "superficial vein thrombosis": 3.24, "superior sagittal sinus thrombosis": 3.25, "thrombolysis": 2.0, "thrombophlebitis": 2.62, "thrombosis mesenteric vessel": 2.43, "thrombosis with thrombocytopenia syndrome": 31.04, "transverse sinus thrombosis": 4.44, "vaccination failure": 3.75, "vaccination site atrophy": 5.46, "vaccination site bruising": 2.06, "vaccination site discomfort": 8.15, "vaccination site haematoma": 4.59, "vaccination site hypersensitivity": 4.5, "vaccination site pain": 2.0, "vaccination site warmth": 2.08, "varicophlebitis": 3.93, "varicose vein": 2.19, "vascular pain": 2.35, "vasodilatation": 2.88, "venous thrombosis": 3.0, "venous thrombosis limb": 2.44, "visceral venous thrombosis": 3.26}